New hope for patients fighting lung cancer.

A recently approved drug shrank tumors in nearly 20 percent of patients tested with the disease.

The drug Keytruda was tested on about 500 patients with advanced lung cancer.

Of the patients who saw improvement – half of them had lasting effects beyond a year.

Join our Newsletter for the latest news right to your inbox